H11.023
Central pterygium of eye, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Central pterygium of the eye is a noncancerous growth of tissue that extends onto the cornea, typically affecting the inner corner of the eye. When this condition occurs in both eyes, it is referred to as bilateral central pterygium. This condition can influence vision and eye health if left untreated. The ICD-10 code H11.023 specifically denotes bilateral central pterygium of the eyes, aiding in medical diagnosis and record-keeping. Understanding the causes, symptoms, diagnosis, and treatment options can help individuals manage this eye condition effectively.
Causes & Symptoms
Clinical Causes: Prolonged exposure to ultraviolet (UV) sunlight Chronic eye irritation from dust, wind, or smoke Exposure to wind or sand in outdoor environments Genetic predisposition may play a role Environmental factors such as dry or dusty conditions
Key Symptoms: Appearance of a fleshy, triangular growth on the cornea Redness and swelling around the affected area Irritation or a feeling of grittiness or foreign body in the eye Blurred vision or visual discomfort if the growth encroaches on the central visual axis Dryness or recurrent inflammation in the eye
Diagnostic & Treatment
Diagnosis Path: Diagnosis of bilateral central pterygium typically involves a comprehensive eye examination by an ophthalmologist. The doctor will visually inspect the eyes, examining the characteristic fleshy growths on the cornea. Additional tests such as slit-lamp microscopy may be employed to assess the extent and severity of the pterygium. In some cases, imaging studies or corneal topography may be utilized to understand the impact on corneal shape and vision, especially before planning surgical intervention if needed.
Treatment Protocols: Treatment options depend on the severity of the pterygium. Many cases are manageable with conservative measures, while others may require surgical removal. Common approaches include: - **Observation:** Monitoring the growth if it is not causing significant symptoms or vision impairment. - **Prevention:** Using UV-protective sunglasses and avoiding prolonged sun exposure to slow progression. - **Medications:** Artificial tears or lubricating eye drops can alleviate irritation and dryness. - **Surgical removal:** Recommended for pterygia that threaten vision, cause significant discomfort, or are cosmetically concerning. Post-surgical measures may include anti-inflammatory eye drops and regular follow-up to reduce recurrence. It's important to discuss with an eye care professional to determine the most appropriate management plan.
Clinical Advice & FAQs
Billing Guidance
Is H11.023 a billable ICD-10 code?
Yes, H11.023 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H11.023?
Clinical documentation must specify the nature of Central pterygium of eye, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
